Try our Advanced Search for more refined results
Health - August, 2009
182 articles
- Walgreen Hits Cephalon Over Provigil Generic Deals
- Miss. AG Hits Teva, Other Pharmas With AWP Suit
- Wyeth Employees' Don, Doff Suit Moves To Trial
- CVS, Others Hit With Suit Over Generics Prices
- Ethicon Loses Bid To Toss Faulty Stapler Suit
- SEC Fraud Claims Against Ex-Centerpulse Exec Pared
- Wholesaler Denied JMOL In Suit Over Sanofi's Arava
- Boehringer IP Atty's Forced Retirement Ruled Illegal
- Derivative Suit Against Cephalon Board, CEO Tossed
- Zimmer, Smith Nephew Settle Bone Screw Patent Spat
- Upcoming HHS/OCR Breach Notification Requirements
- Defunct La. Hospital Slams Insurer With $59M Suit
- Judge Keeps Neurontin Case Against Pfizer Intact
- 6th Circ. Affirms Dismissal Of Fen-Phen Case
- 7th Circ. Remands $37M Fine For Weight-Loss Guru
- Zimmer Slapped With Patent Suit Over Prosthetic Hips
- Bausch Wins Bid To Boot Expert From ReNu MDL
- FDA's Head Of Medical Devices Steps Down
- FDA Lacks Data To Back Funding Requests: Report
- Experts Call FDA's Device Approval Process Flawed
- Digitek Plaintiffs Must Produce Info
- Health Insurance Price-Fixing Suits Merged Into MDL
- FDA Restricts Clinical Trial Review Board Over Safety
- Mass. AG Accuses Mylan, Others Of Medicaid Fraud
- Kaiser, Project Managers Settle FLSA Suit For $1.4M
- Fed. Circ. Revives Part Of Ortho-McNeil Ultracet Saga
- Mallinckrodt Damages Limited In E-Z-EM Injector Spat
- Punitive Damages Bid Tossed In ObTape MDL
- 2nd Circ. Hands GSK A Win In Avandia Securities Suit
- Wyeth Loses Bid To Oust Howrey From Stent Suit
- FDA Reviewing Safety Of Popular Weight-Loss Drug
- Cipro Pay-For-Delay Deal Was Within Calif. Law: Court
- Allergan Warning May Prompt Suits By AGs: Expert
- HP, Others Sued Over Videoconferencing Patent
- Calif. Pharmacies Sue Pfizer Over Wyeth Merger
- Radiologist Targets Abbott Labs Over Stent Patent
- Citigroup Argues KV Pharma Knew ARS Risks
- Boston Scientific Stent Patent Spat Booted From Del.
- 3 Classes OK'd In Cosmetic Clinic Workers' OT Suit
- Warner Chilcott To Buy P&G Drug Biz For $3.1B
- Medtronic, WL Gore Settle Stent Patent Dispute
- Quebec Judge Rejects Class Action For Paxil Claims
- Qualitest Recalls Two Lots Of Insulin Syringes
- Nutracoastal Recalls, Stops Distributing 'Steam'
- Fed. Circ. To Revisit Ariad, Lilly IP Dispute En Banc
- Antitrust Claims Nixed In Dialysis Clinics' Contract Spat
- LadaTech Sues Illumina Over DNA Analysis Patent
- Maximizing Biotech Patent Protection On A Budget
- Biovail's Hedge Fund Fraud Suit Gets Tossed
- Lilly To Pay $22.5M To Settle W.Va. Zyprexa Claims
- 9th Circ. Rejects Rehearing On Norvir Antitrust Deal
- New Ill. Ethics Rules For 'Reporting Up'
- Rite Aid, CVS Hit Cephalon With New Provigil Suit
- MediciNova, Avigen Merge To Boost Ibudilast Efforts
- No Brand Drugs For Iowa Medicaid Patients: 8th Circ.
- Plaintiffs To Appeal NY Ruling Over ReNu Solution
- FDA Warns Cos. About Marketing Ibuprofen Products
- Doctor's Deposition To Be Shown In Fosamax Trial
- Court Won't Change Inventorship In Zicam IP Suit
- Viagra MDL Plaintiffs Lose Star Expert Witness
- Bayer Dealt Blow In Nexavar Feud With Cipla
- Method Patents Not Covered By 271(f): Fed. Circ.
- Merck Wins Block On Teva's Generic Singulair
- Merck Seeks To Toss Doctor's Fosamax Testimony
- 5th Circ. Unsure Of Jurisdiction For Aetna Suit
- Neuralstem Asks Judge To Rethink Trade Libel Ruling
- Medicis Clears Up Acne Drug Dispute With Sandoz
- Health Fund Takes Seroquel Fraud Suit To 11th Circ.
- Synergetics Can't Claim Price Coercion In Alcon Suit
- Mylan Fights Decision Blocking Generic Benicar
- Communicating Effectively When Bad News Breaks
- USPTO Grants Apotex's Bid To Review Plavix Patent
- Medtronic Units Appeal Globus Patent Judgment
- Eli Lilly Method Patent For Gemzar Found Invalid
- Fen-Phen Atty Holds On To $5.7M Arbitration Award
- Drug Co-Op Accuses Boehringer Of Mirapex Monopoly
- Novo Fights To Nix Counterclaims In Prandin IP Suit
- The DOJ Stance On Reverse Payment Settlements
- Ex-Lawyers Get 20, 25 Years In Fen-Phen Fraud Case
- Purdue Pharma's Ultram Patents Deemed Invalid
- High Court Asked To Limit Juries' Role In Patent Suits
- Bayer Sues J&J Unit Over Arthritis Drug
- Sanofi Appeal Puts Hospira's Generic Eloxatin On Hold
- Hospira Recalls Medical Devices For Faulty AC Cords
- Align Settles Orthodontics Patent War In $90M Deal
- GSK Sues Glenmark Over Malarone Patents
- Barr Recalls Oversized Adderall Batch
- Judge Greenlights Aredia Cases Against Novartis
- Science Cos. Clash Over Failed Spine Screw Deal
- TET, Pharmasset Settle Spat Over Gene Test Patent
- Kappos Promises To Reform USPTO
- Rite Aid, CVS File New HIV Drug Price Complaint
- Post-Claim Underwriting: Calif.'s Dirty Secret
- NJ Judge Rejects 2nd Attempt To Certify Vioxx Action
- FDA Clears Mylan Over Ignored Computer Warnings
- Schering Prevails In Patent Suit Over Pig Vaccine
- Antitrust Suit Says Merck Blocking Generic Singulair
- Medline Sues 3M Over Hand Scrub Ads
- Demand For The Patented Product — Lower Bar?
- Class Cert. For 20K Nurses Sought In Wage Case
- Covington Snags Ala. Atty Who Won Vioxx Suits
- Miller Canfield Picks Up Pfizer Patent Expert
- 1st Circ. Revives Qui Tam Claims Over Procrit AWP
- Sanofi, Watson Resolve Patent Dispute Over Plavix
- Opening Salvo Fired In Fosamax Trial
- Schering, Orchid Settle Clarinex Patent Suit
- Magistrate Pushes To Keep Iovate Patent Suit Alive
- Expert Testimony Excluded Again In Accutane MDL
- NuvaRing Maker Ordered To Pay E-Discovery Costs
- Merck Swaps Lead Attorney For Vioxx Appeal
- Judge OKs $925M UnitedHealth Deal, Slashes Fees
- Cordis Stent Patents Found Enforceable On Remand
- Plaintiffs Reload In Cephalon Antitrust Litigation
- Ill. Enacts New Green Laws For Water, Drugs
- Obama Vows To Speed Generic-Drug Access
- Wellbutrin Plaintiffs Step Up Fight For Docs' Release
- Bloomberg Wins Bid To Unseal Seroquel Docs
- Judge Won't Dismiss Mich. Blue Cross ERISA Suit
- Abbott Sues Centocor Over Psoriasis Drug Patents
- Judge Upholds Expanded Discovery In Digitek Case
- Watson Recalls Fentanyl Patches Due To Leak Risk
- Optometrist Makes Antitrust Claims In CIBA IP Suit
- FDA Speeds Up Disciplining Of Wayward Researchers
- Ariz. Nurses Seek Class Reconsideration In Cartel Suit
- Silicon Valley Venture Capital Survey Shows Weak Q2
- Medical Device Maker Sued For Infringement, Libel
- Revisiting Ariad V. Eli Lilly
- Surgical Appliances Hit With Breast Prosthesis IP Suit
- Miss. AG's Suit Ousted From Vitamin MDL
- Bilski Test Stifles Innovation Across Industries: Briefs
- Subpoena Of Scientist Quashed In Fosamax MDL
- Zyprexa Failure-To-Warn Suit Survives In MDL
- FTC Seeks More Info On Watson, Arrow Merger
- Texas MDL Panel Consolidates Mylan Cases
- Insurer Ordered To Cover ORI In Amputated Toes Suit
- Class Cert. Denied In Suit Over Bayer's WeightSmart
- Court Approves $10M Settlement In Norvir Pricing Suit
- Schering-Plough Denied Injunction In Sunscreen Suit
- Wyeth, Pfizer Resolve Investor Suits Over Merger
- Bilski Test Too Tough On Patent Eligibility: Briefs
- Organon Loses Bid To Nix NuvaRing Complaint
- Teva Sues Merrill Over ARS Gone Bad
- Mayer Brown Snags Fish & Richardson IP Partner
- Elan Sues Over Biogen Objection To $1B J&J Deal
- Jury Hands Medtronic $57M In Alloy Suit Against AGA
- FDA Urges Melamine Testing On Drug Products
- India To Launch WTO Battle Over EU Drug Seizures
- Antitrust Law Can't Touch State Hospice Regs: Wash.
- FDA Head Promises Enforcement Crackdown
- C&D Appeals $29.2M Award In Pregnancy Test Suit
- Investors Hit Spectranetics With Fraud Suit
- Fed. Circ. Affirms Invalidity Of Bayer's Yasmin Patent
- Abbott To Try For Summary Judgment In TriCor Suit
- Merck, Schering Offer $42M To Settle Vytorin Suits
- Covidien Loses Bid To Block Generic Restoril
- J&J Unit Eyed Over Clinical Reviewers
- StemCells Claims Survive In Libel Suit Over IP Spat
- Revamping The False Claims Act
- FDA Orders Cancer Warning For TNF Blockers
- Navinta Infringed Abraxis' Naropin Patents: Judge
- ICU, Medegen Settle IV Connection Patent Spat
- Daiichi Earns Win Against Mylan Over Benicar Patent
- 9th Circ. Affirms NLRB Ruling In Hospital OT Spat
- Clarifying Time Limits For Follow-On Damages Claims
- Osteotech, RTI Near Deal In Bone Cleaning IP Suit
- Merck To Pay $80M To Settle Vioxx Suits
- J&J Hits CIBA Vision Over Contact Lens Patents
- FDA Halts Production Of Teva Animal Drugs
- Digitek MDL Claims Survive Motions To Dimiss
- India's OmniActive Must Face US Patent Suit: Court
- Genzyme Hits Roxane With Suit Over Hectorol ANDA
- J&J Workers Renew Cert. Bid In Race Bias Action
- Colgate Sues J&J Over Total Trademark
- La. Told To Produce Docs In Zyprexa MDL
- Swath Of Claims Cut From Wellbutrin Antitrust Action
- FDA, EMEA Launch Clinical Trial Oversight Program
- Sun Pharma Settles Patent Suits Over Generic Ethyol
- House Panel Adds Pay-For-Delay Ban To Health Bill
- Clarcon Skin Products Seized Amid Bacteria Scare
- Thoratec, HeartWare Abandon Merger Talks
- GSK's Preemption Argument Fails To Stop Paxil Case
- Responding To Semi-Objectionable Discovery